Champions Oncology Net Debt Growth & History (CSBR)

Champions Oncology's net debt was −$275,000 for fiscal 2026.

View full Champions Oncology company overview

Champions Oncology annual net debt history

Champions Oncology annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20262026-04-30−$275,000$3.2M
20252025-04-30−$3.5M−$8.6M
20242024-04-30$5.2M$6.6M
20232023-04-30−$1.4M−$1.9M
20222022-04-30$531,000−$4.4M−89.19%
20212021-04-30$4.9M$9.5M
20202020-04-30−$4.5M−$1.3M
20192019-04-30−$3.2M−$2.4M
20182018-04-30−$813,000$2.4M
20172017-04-30−$3.3M−$731,000
20162016-04-30−$2.5M

Champions Oncology net debt trends

Over the last five fiscal years, Champions Oncology's net debt decreased from $4.9M to −$275,000, a change of −$5.2M. The latest reported quarter, Q4 2026, shows −$275,000.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Champions Oncology source filings ↗

Community posts

It’s quiet here.

No posts about CSBR yet. Start the conversation.

Write the first post